Journal article

The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense

MT Harte, IR Haga, G Maloney, P Gray, PC Reading, NW Bartlett, GL Smith, A Bowie, LAJ O'Neill

Journal of Experimental Medicine | ROCKEFELLER UNIV PRESS | Published : 2003

Abstract

Toll-like receptors (TLRs) are crucial in the innate immune response to pathogens, in that they recognize and respond to pathogen associated molecular patterns, which leads to activation of intracellular signaling pathways and altered gene expression. Vaccinia virus (VV), the poxvirus used to vaccinate against smallpox, encodes proteins that antagonize important components of host antiviral defense. Here we show that the VV protein A52R blocks the activation of the transcription factor nuclear factor κB (NF-κB) by multiple TLRs, including TLR3, a recently identified receptor for viral RNA. A52R associates with both interleukin 1 receptor-associated kinase 2 (IRAK2) and tumor necrosis factor ..

View full abstract

University of Melbourne Researchers